ouabain has been researched along with Cardiotoxicity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botelho, AFM; Canta, GN; da Cruz, JPO; da Silva Ferreira, R; Fernandes, PBU; Lempek, MR; Mantovani, MM; Melo, MM; Silva, FLA; Veado, JCC | 1 |
| Barreto, T; Botelho, AFM; Cruz, JS; Freitas, TG; Melo, MM; Milani, PF; Miranda, ALS | 1 |
| Bögeholz, N; Eckardt, L; Ellermann, C; Frommeyer, G; Lange, PS; Leitz, P; Puckhaber, D; Wolfes, J | 1 |
| Cheng, XL; Ren, YR; Xu, MX; Yin, QS; Zhang, L; Zhang, YJ; Zhu, CY; Zhuang, PW | 1 |
4 other study(ies) available for ouabain and Cardiotoxicity
| Article | Year |
|---|---|
Comparative Therapeutic Potential of Cardioactive Glycosides in Doxorubicin Model of Heart Failure.
Topics: Animals; Cardenolides; Cardiac Glycosides; Cardiotonic Agents; Cardiotoxicity; Digoxin; Disease Models, Animal; Doxorubicin; Heart Failure; Ouabain; Rats, Wistar; Recovery of Function; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2022 |
Comparative Cardiotoxicity of Low Doses of Digoxin, Ouabain, and Oleandrin.
Topics: Animals; Antioxidants; Cardenolides; Cardiotoxicity; Digoxin; Dose-Response Relationship, Drug; Heart; Heart Diseases; Heart Rate; Male; Myocytes, Cardiac; Necrosis; Ouabain; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Ventricular Remodeling | 2020 |
Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotoxicity; Digitalis Glycosides; Drug Interactions; Flecainide; Heart Rate; Isolated Heart Preparation; Ouabain; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Risk Assessment; Time Factors; Voltage-Gated Sodium Channel Blockers | 2019 |
Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
Topics: Animals; Animals, Newborn; Cardiotoxicity; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression Profiling; Gene Expression Regulation; Genetic Markers; Heart Diseases; Heart Rate; Isoproterenol; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Ouabain; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases, 70-kDa; Toxicity Tests | 2017 |